Chemical Compound

Miniglucagon

CAS Registry Number 64790-15-4
Back to search Request a Quote
Miniglucagon chemical structure
Primary Record

Miniglucagon

In stock
2,959 g
Purity
99.6 %
CAS
64790-15-4

Compound Identifiers & Properties

CAS
64790-15-4
PubChem CID
3080901
SMILES
C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O
Canonical SMILES
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O

Names & Synonyms

  • Miniglucagon
  • Glucagon (19-29), human
  • Glucagon(19-29)
  • Glucagon (19-29)
  • Des(1-18) glucagon
  • 64790-15-4
  • AC1MIVXR
  • H-AQDFVQWLMNT-OH
  • Glucagon-[19-29]
  • RefChem:143581
  • Mosapride citrate dihydrate
  • H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH
  • Glucagon(19-29)[human]
  • Miniglucagon (human, rat, porcine)
  • orb1679480
  • C61H89N15O18S
  • SCHEMBL28674492
  • MFCD00076518
  • SVHJFTNFNMWDBS-FPLSMPAJSA-N
  • HY-P0150
  • BAT-010207
  • CID3080901
  • Glucagon (19-29) (human, rat, porcine)
  • C61-H89-N15-O18-S
  • DA-53593
  • FG108770
  • MS-32130
  • DB-277144
  • J668.904C
  • CS-0019925
  • G12236
  • A899854
  • Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt
  • GLUCAGON (19-29) (HUMAN,BOVINE,PORCINE)
  • ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR
  • (2S,5S,8S,11S,14S,17S,20S,23S,26S)-14-((1H-indol-3-yl)methyl)-26-((S)-5-amino-2-((S)-2-aminopropanamido)-5-oxopentanamido)-5-(2-amino-2-oxoethyl)-17-(3-amino-3-oxopropyl)-23-benzyl-2-((R)-1-hydroxyethyl)-11-isobutyl-20-isopropyl-8-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25-octaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanedioic acid
  • (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid
  • Glucagon (19-29) (human, rat, porcine) Miniglucagon (huMan, rat, porcine)
  • L-Threonine, N-(N2-(N-(N-(N-(N2-(N-(N-(N-(N2-L-alanyl-L-glutaminyl)-L-alpha-aspartyl)-L-phenylalanyl)-L-valyl)-L-glutaminyl)-L-tryptophyl)-L-leucyl)-L-methionyl)-L-asparaginyl)-
  • (2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-carboxypropanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid
  • (3S)-4-[[(1S)-2-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-3-amino-1-[[(1S,2R)-1-carboxy-2-hydroxy-propyl]carbamoyl]-3-oxo-propyl]carbamoyl]-3-methylsulfanyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]carbamoyl]-2-methyl-propyl]amino]-1-benzyl-2-oxo-ethyl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxo-pentanoyl]amino]-4-oxo-butanoic acid
  • (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1,3-dihydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid
  • 636582-62-2
  • L-Threonine,L-alanyl-L-glutaminyl-L-a-aspartyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-leucyl-L-methionyl-L-asparaginyl-